New PET tracer could spot hidden cancers
NCT ID NCT03604315
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase I trial is testing a new radioactive tracer called [18F]FTT, which is used with PET/CT scans to find tumor cells in people with solid tumors, including breast, ovarian, and other cancers. The study will enroll 300 participants and aims to see how well the tracer highlights cancer cells compared to standard imaging. It is not a treatment but a way to improve cancer detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fluorine F 18 Fluorthanatrace ([18F]FTT)
- What this could lead to
- If successful, this imaging method could help doctors better detect and monitor certain cancers, like ovarian or breast cancer, by highlighting tumor cells more clearly.
- What could go wrong
- This is an early phase I study focused on imaging, not treatment. The tracer may not work as hoped, and results may not apply to all patients or cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shrink Hard-to-Treat gynecological tumors?
- Phone-Based navigation could boost breast cancer detection in kenya
- Can heated chemotherapy improve ovarian cancer outcomes?
- Can engineered immune cells target a common ovarian cancer protein?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can an immune booster help chemotherapy fight metastatic breast cancer?